CD274 and breast cancer: The meta-analysis showed that PD-L1 overexpression was associated with shorter OS in patients with breast cancer than the absence of PD-L1 expression in patients with breast cancer (HR= 1.76, 95% CI 1.09–2.82; P=0.02).